Neutrophil-Lymphocyte Ratios in Dry Age-Related Macular Degeneration

Sannan Naif1,2,3, Ramadan Majed2,3, Elsayid Mohieldin1,2

  • 1Department of Clinical Laboratory Sciences, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.

Insights

The neutrophil-lymphocyte ratio (NLR) did not significantly predict dry age-related macular degeneration (AMD). While NLR was slightly higher in dry AMD patients, other routine lab tests may offer better early disease prediction.

Area of Science:

  • Ophthalmology
  • Immunology
  • Gerontology

Background:

  • Inflammation is implicated in the development of age-related macular degeneration (AMD).
  • The neutrophil-lymphocyte ratio (NLR) is a marker of systemic inflammation.
  • Assessing systemic inflammatory markers may aid in understanding dry AMD pathogenesis.

Purpose of the Study:

  • To evaluate the neutrophil-lymphocyte ratio (NLR) as a potential biomarker for dry age-related macular degeneration (AMD).
  • To determine if NLR can serve as an indicator of systemic inflammation in dry AMD patients.

Main Methods:

  • A retrospective case-control study design.
  • Inclusion of 90 patients with dry AMD and 270 age/sex-matched controls.
  • Analysis of complete blood count (CBC) data to calculate NLR.

Main Results:

  • No significant differences were found in CBC results between dry AMD patients and controls.
  • Mean NLR was slightly elevated in the dry AMD group, but this difference was not statistically significant (P = .13).
  • Age and sex were significant factors influencing NLR in the dry AMD group (P = .03 and P = .01, respectively).

Conclusions:

  • The neutrophil-lymphocyte ratio (NLR) alone is not a reliable predictor of dry age-related macular degeneration (AMD).
  • Further research into other routine laboratory measurements is recommended for early disease prediction and prevention strategies.

Related Concept Videos